Citius Pharmaceuticals, Inc. (CTXR) stock
CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.54+0.00 (+0.51%)
Close on Nov 13, 2026Market cap $14.69MP/E –Yield –
Citius Pharmaceuticals gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2018 it was 0.0%, against 0.0% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2018 | Sep 30, 2018 | 0.0% | +0.0 |
| FY2017 | Sep 30, 2017 | 0.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | 67.1% | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | 80.3% | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | 80.0% | – |
See a number that looks wrong?